Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Other material
confidence 65%
filed 2026-05-29
Item 2.02
The disclosure announces a board decision to consider resumption of quarterly dividends and schedule a special meeting for July 29, 2026. While filed under Item 2.02 (Results of Operations and Financial Condition), the substance is a corporate governance/capital allocation announcement rather than a financial results disclosure. Dividend resumption is material to shareholders but does not fit cleanly into earnings_release, exec_compensation, or shareholder_vote_results categories, warranting classification as other_material.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 94%
filed 2026-05-29
Item 1.01
The Company issued a $750,000 convertible promissory note with a principal face value of $937,500 to an accredited investor under Section 4(a)(2) exemption. The note is convertible into common stock at a price equal to the lesser of $0.05 or 80% of the average of the 5 lowest intraday trading prices in the prior 20 days, with a registration statement required for resale of conversion shares.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-29
Item 3.03
Stockholders approved an amendment to the Company's Certificate of Incorporation at the May 22, 2026 Annual Meeting increasing authorized shares of common stock from 312.3 million to 452.8 million shares and preferred stock from 24.1 million to 34.9 million shares, materially expanding the Company's capacity to issue equity.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-05-29
Item 1.01
Treasure Global Inc entered into a Subscription Agreement to issue and sell $1,200,000 of common stock shares in a private placement to Legacy Trustee Berhad under Regulation S, structured in four tranches with resale restrictions under Rule 144. The Company must register the shares for resale within 60 days, materially diluting existing shareholders.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-05-29
Item 5.07
The filing explicitly discloses Item 5.07 regarding "voting results and the conclusion of the Annual Meeting" with a press release issued on May 25, 2026. This is a direct disclosure of shareholder vote results from an annual meeting, which is the core definition of the shareholder_vote_results event type. Annual meeting voting outcomes are material to investors as they determine board composition and approval of key corporate matters.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-29
Item 8.01
The disclosure describes the consummation of Aperture AC's IPO on May 22, 2026, raising $102 million in gross proceeds from the sale of 10.2 million units at $10.00 per unit, plus a concurrent private placement of 311,000 units for $3.11 million. While this is a material capital-raising event affecting the registrant's financial position, it does not fit cleanly into the earnings_release, ma_activity, or dilutive_issuance categories—it is a SPAC IPO with trust account mechanics rather than a traditional equity offering or M&A transaction. Classified as other_material given its significance to a reasonable investor but lack of precise categorical fit.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-29
Item 2.03
The Company drew $5,000 thousand under an unsecured promissory note from its sponsor to extend its business combination deadline from May 29, 2026 to June 29, 2026. While this creates a direct financial obligation (Item 2.03), it is a routine extension mechanism for a SPAC that does not fit neatly into the more specific event categories. The disclosure is material because it signals continued inability to close a business combination and reliance on sponsor funding, which affects investor assessment of the Company's prospects.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 98%
filed 2026-05-29
Item 3.01
Aditxt received a formal delisting notice from Nasdaq on May 27, 2026, citing failure to satisfy the minimum stockholders' equity requirement of $2.5 million (the company reported negative equity of $35.2 million). The filing explicitly discloses multiple listing deficiencies—stockholders' equity, minimum bid price, and market value of publicly held shares—and states that the Nasdaq Hearings Panel will determine whether to delist the company's securities. The disclosure directly invokes delisting risk under Item 3.01 and references substantial doubt about going concern, making this a clear and material delisting notice.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-05-29
Item 5.02
The filing discloses the appointment of Akiko Moni Miyashita as a director of Averin Capital Acquisition Corp., effective May 28, 2026. The principal action is a person taking a board role, with detailed biographical information provided. As a SPAC director appointment, this is material to investors assessing the company's governance and business combination prospects.
View raw filing on EDGAR →
8-K
Auditor Change
confidence 98%
filed 2026-05-29
Item 4.01
The filing discloses a change in the registrant's independent accountant: PricewaterhouseCoopers LLP was dismissed and Ernst & Young LLP was engaged as the new independent registered public accounting firm, effective May 26, 2026. This is a textbook auditor change under Item 4.01. The disclosure includes the required confirmations that prior audit reports were unqualified and there were no disagreements or reportable events, which are standard representations in auditor-change filings.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-05-29
Item 3.02
CID HoldCo issued a senior secured convertible promissory note with a principal amount of $287,500 (cash proceeds of $230,000) to White Lion Capital, LLC on May 29, 2026, convertible into common stock at a variable conversion price of 80% of the lowest VWAP during a 15-day period. The unregistered issuance relies on Section 4(a)(2) and Regulation D exemptions and materially affects shareholder equity and voting power.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 92%
filed 2026-05-29
Item 5.02
CEO Edmund Nabrotzky, CFO Charles Maddox, CTO Vijayan Nambiar, and CRO (Mrs. Rochester) have voluntarily agreed to reduce and defer their base salaries, with amendments to employment agreements and deferral agreements executed as part of cost-saving measures.
View raw filing on EDGAR →
8-K
Going Concern
confidence 75%
filed 2026-05-29
Item 8.01
The company implemented a temporary employee furlough to preserve liquidity while evaluating financing opportunities, coupled with executive salary deferrals and explicit references in forward-looking statements to substantial doubt about the company's ability to continue as a going concern.
View raw filing on EDGAR →
8-K
Other material
confidence 55%
filed 2026-05-29
Item 8.01
The 8-K discloses two press releases announcing "business developments" on May 20 and May 27, 2026, along with a "Pre-Paid Purchase" agreement with Streeterville Capital dated May 22, 2026. Without access to the actual press release content, the specific nature of these developments cannot be determined from the Item 8.01 disclosure alone. The reference to a pre-paid purchase agreement suggests potential financing or capital activity, but the exact materiality and event classification depend on the substance of the announcements, which are incorporated by reference but not detailed in the filing excerpt provided.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-05-29
Item 8.01
The filing announces the scheduling of an extraordinary general meeting on June 16, 2026, for Live Oak shareholders to vote on the "previously announced initial business combination transaction" with Teamshares Inc. The disclosure centers on the advancement of a material acquisition/merger—specifically, the announcement of the shareholder meeting date, effectiveness of the Registration Statement on Form S-4, and the Record Date. This is a critical milestone in the M&A process and directly material to investors assessing the registrant's strategic direction and capital structure.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 98%
filed 2026-05-29
Item 3.01
Actinium Pharmaceuticals received a notice from NYSE American on May 27, 2026, indicating non-compliance with continued listing standards due to stockholders' equity of $2.3 million falling below the required $4.0 million threshold while reporting net losses in five consecutive fiscal years. The company must submit a compliance plan by June 26, 2026, or face delisting proceedings.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-29
Item 7.01
The company provided a material update on the development program for ATNM-400, a product candidate, disclosed via press release in connection with receipt of a Notice.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-05-29
Item 5.07
This is a Form 8-K Item 5.07 disclosure of shareholder vote results from the reconvened 2025 Annual Meeting of Stockholders held on May 29, 2026. The filing reports voting outcomes for three proposals: election of a Class I director (Arphing Lee), ratification of Bush & Associates CPA LLC as independent auditor, and approval of the 2025 Stock Incentive Plan. All three proposals passed, making this a material disclosure of shareholder actions that affects the composition of the board and approval of equity compensation arrangements.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-05-29
Item 2.01
Matternet completed an acquisition or disposition of assets, as disclosed under Item 2.01. This transaction materially affects the registrant's asset base and strategic direction.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-05-29
Item 5.01
Matternet experienced a change in control of the registrant, as disclosed under Item 5.01. This change-of-control event materially affects the registrant's governance and ownership structure.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-05-29
Item 3.02
Matternet completed an unregistered sale of equity securities, as disclosed under Item 3.02. This dilutive issuance materially affects ownership dilution and capital structure.
View raw filing on EDGAR →
8-K
Auditor Change
confidence 95%
filed 2026-05-29
Item 4.01
Matternet changed its independent accountant, as disclosed under Item 4.01. This auditor change is material to investors as it may signal underlying accounting or governance concerns.
View raw filing on EDGAR →
8-K
Other material
confidence 35%
filed 2026-05-29
Item 1.01
Matternet entered into a material definitive agreement, as disclosed under Item 1.01. Without substantive details on the agreement's parties, terms, or business purpose, the specific event classification cannot be determined with confidence.
View raw filing on EDGAR →
8-K
Other material
confidence 45%
filed 2026-05-29
Item 3.03
Matternet made a material modification to the rights of security holders, as disclosed under Item 3.03. The specific nature of the modification (e.g., charter amendment, voting rights change) cannot be determined from the item heading alone.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-29
Item 5.06
Matternet experienced a change in shell company status, as disclosed under Item 5.06. This change materially affects the registrant's regulatory classification and investor protections.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 90%
filed 2026-05-29
Item 3.02
Ondas Inc. completed an unregistered sale of equity securities under Section 4(a)(2) and Regulation D, Rule 506 exemptions, representing a material private placement that affects shareholder dilution and the company's capital structure.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-29
Item 8.01
WisdomTree disclosed entry into privately negotiated repurchase agreements to buy back approximately $51.9 million in principal amount of its 3.25% Convertible Senior Notes due 2029 for $87.3 million in cash. This is a material capital allocation and debt reduction event that would affect investor assessment of the company's financial position and leverage, but it does not fit cleanly into the more specific event categories (not M&A, not a covenant breach, not a dilutive issuance). The transaction is material and disclosed under Item 8.01 as an "Other Event."
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-29
Item 5.07
This Item 5.07 disclosure presents the complete results of The Mosaic Company's 2026 Annual Meeting of Stockholders, including voting tallies for director elections (all twelve directors elected), ratification of KPMG LLP as independent auditor, and advisory approval of executive compensation. The detailed vote counts for each matter are the core content of a shareholder_vote_results event.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-29
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Roblox's 2026 Annual Meeting of Stockholders held on May 28, 2026. The filing presents voting outcomes for three proposals: election of three directors (David Baszucki, Gregory Baszucki, and Dennis Durkin), advisory approval of named executive officer compensation, and ratification of Deloitte & Touche LLP as independent auditor. The detailed vote tallies (votes for, against, abstentions, and broker non-votes) are the core content of this Item 5.07 disclosure.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-29
Item 2.03
This Item 2.03 disclosure describes the issuance of consolidated obligations (bonds and discount notes) by the Federal Home Loan Bank of Des Moines, which are joint and several obligations of all eleven Federal Home Loan Banks. While the filing creates direct financial obligations through debt issuance, the prose emphasizes that the Bank has "not made a judgment as to the materiality of any particular consolidated obligation or obligations" and focuses on regulatory framework and reporting methodology rather than a specific material debt event. The disclosure is material to the Bank's operations but does not fit cleanly into the covenant_breach or other specific debt-related categories, as it describes routine consolidated obligation issuance mechanics rather than a triggering financial event.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-29
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Employers Holdings' 2026 annual meeting of stockholders held on May 28, 2026. The filing presents voting results for three matters: election of eight directors, advisory approval of named executive officer compensation, and ratification of Ernst & Young LLP as independent auditor. The detailed vote tallies (for, against, abstentions, broker non-votes) for each director and proposal are the core content of the filing, making this unambiguously a shareholder_vote_results event.
View raw filing on EDGAR →
8-K
M&A activity
confidence 97%
filed 2026-05-29
Item 2.01
Tiptree completed the sale of Fortegra to an undisclosed Purchaser for $1.65 billion in cash (approximately $1.08 billion net to Tiptree after adjustments) on May 29, 2026. In connection with the merger closing, Tiptree entered into material credit facility amendments and consents (South Bay Consent and FFC Amendment) to obtain lender approval for the change of control and address going-concern qualifications, and terminated the Fortress Credit Agreement with repayment of all obligations.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-29
Item 5.07
This Item 5.07 filing discloses the final results of American Coastal Insurance's 2026 Annual Meeting of stockholders, including voting outcomes for two proposals: election of five Class B directors and ratification of Deloitte & Touche, LLP as independent auditor. The detailed vote tallies (For, Against, Abstained, Broker Non Votes) for each director and the auditor ratification are the core disclosure, making this a textbook shareholder_vote_results event that is material to investors assessing board composition and audit oversight.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-05-29
Item 8.01
AGNC Investment Corp. entered into "at the market" (ATM) sales agreements with 14 major financial institutions to offer and sell up to $2 billion in common stock. This is a classic dilutive equity issuance disclosed under Item 8.01, with the potential to significantly increase share count and dilute existing shareholders. The magnitude ($2 billion) and structure (ATM program with multiple agents) are material to investors assessing capital structure and shareholder value.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-29
Item 7.01
The disclosure announces new clinical data for Moleculin's lead drug candidate Annamycin presented at ASCO, highlighting a "differentiated cardiac safety profile." This is material clinical trial progress for a biotech company with a lead candidate in development, as it addresses a critical safety concern that could influence investor assessment of the drug's commercial viability and regulatory pathway. However, it does not fit neatly into earnings_release (no financial results), material_litigation, or other more specific categories, making other_material the most appropriate classification.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-29
Item 5.07
This is a clear disclosure of shareholder vote results from Broadwind's Annual Meeting of Stockholders held on May 28, 2026. The filing reports voting outcomes on three matters: (i) election of five directors, (ii) non-binding advisory vote on named executive officer compensation ("Say-on-Pay"), and (iii) ratification of RSM US LLP as independent auditor. All three votes passed with substantial majorities. This is a routine but material disclosure required under Item 5.07 of Form 8-K.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 92%
filed 2026-05-29
Item 5.02
The disclosure centers on a new employment agreement with CEO Michael Benstock entered into on May 26, 2026, detailing comprehensive compensatory arrangements including base salary ($1,044,399), guaranteed bonuses ($500,000 annually for 2026-2028), a $2,100,000 retention bonus, severance multiples (2.0x highest annual compensation), and equity acceleration provisions. While the agreement also addresses employment terms and conditions, the material substance is the negotiated compensation package and severance structure, which would materially affect investor assessment of executive costs and change-of-control obligations.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-29
Item 5.07
This is a clear disclosure of shareholder vote results from HealthStream's May 28, 2026 annual meeting, covering three proposals: election of three Class II directors, ratification of Ernst & Young LLP as independent auditor, and approval of a non-binding say-on-pay resolution. The filing presents final vote tallies for each proposal, which is the quintessential content of Item 5.07 disclosures and materially informs investors about shareholder governance actions.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-29
Item 7.01
Monopar disclosed Phase 2 clinical trial results for ALXN1840 (tiomolibdate choline) in Wilson disease patients presented at a major medical conference (EASL 2026). While this represents material clinical progress for a therapeutic candidate, it does not fit neatly into the standard taxonomy categories (not an earnings release, M&A activity, executive change, or financial restatement). Clinical trial results presented at conferences are typically material to investors assessing pipeline value and development progress, warranting classification as other_material.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-29
Item 5.07
This is a classic Item 5.07 disclosure reporting the final results of Coastal Financial's 2026 annual meeting of shareholders held on May 27, 2026. The filing presents voting results for three matters: election of directors (Delorier, Hovde, Patterson, Tisdel, and Chapman), ratification of Baker Tilly US, LLP as independent auditor, and an advisory vote on executive compensation. The detailed vote tallies (For/Against/Abstain/Broker Non-Votes) for each proposal are the core content of this disclosure, which is material to investors assessing corporate governance and board composition.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-29
Item 5.07
This Item 5.07 disclosure reports the results of SiTime Corporation's Annual Meeting of Stockholders held on May 29, 2026, with voting tallies for three proposals: election of three Class I directors (Torsten G. Kreindl, Ganesh Moorthy, and Akira Takata), advisory approval of named executive officer compensation, and ratification of Deloitte & Touche LLP as independent auditor. The detailed vote counts (For, Against/Withheld, Abstain, and Broker Non-Votes) for each proposal are the core disclosure, which is the defining characteristic of shareholder vote results under Item 5.07.
View raw filing on EDGAR →
8-K
Material Litigation
confidence 92%
filed 2026-05-29
Item 1.01
The filing discloses settlement of putative federal antitrust class action litigation (In re: PVC Pipe Antitrust Litigation) with two of three plaintiff classes, involving aggregate settlement payments of $73.5 million ($39.5 million to Direct Purchasers and $34.0 million to Non-Converter Seller Purchasers). This material litigation settlement would significantly affect a reasonable investor's assessment of the company's financial exposure and legal risk, even though the company does not admit wrongdoing.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 95%
filed 2026-05-29
Item 8.01
The filing discloses receipt of a deficiency letter from Nasdaq on April 17, 2026, notifying Expensify that its Class A common stock had fallen below the $1.00 minimum bid price requirement for continued listing on The Nasdaq Global Select Market under Listing Rule 5450(a)(1). Although the Company subsequently regained compliance by May 28, 2026, the initial deficiency notice and the period of non-compliance constitute a material delisting risk event that would affect investor assessment of the registrant's listing status.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-05-29
Item 1.01
Classover Holdings sold $600,000 principal amount of senior secured convertible notes to an investor under a Securities Purchase Agreement amendment, with conversion rights into Class B common stock and an option for the buyer to purchase up to an additional $339 million in notes. The unregistered sale under Section 4(a)(2) and convertible structure constitute a material dilutive financing arrangement.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-29
Item 5.03
Classover Holdings, Inc. amended its certificate of incorporation to change its legal name to 'KIDZ AI Inc.' effective May 26, 2026. The corporate name change is a material event affecting investor identification and security trading.
View raw filing on EDGAR →
8-K
M&A activity
confidence 65%
filed 2026-05-29
Item 2.03
Item 2.03 discloses creation of a direct financial obligation and incorporates by reference Item 1.01, indicating a material acquisition or merger with associated financing obligations underlying the convertible note transaction.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 98%
filed 2026-05-29
Item 3.01
Edible Garden received a notice from Nasdaq on May 27, 2026 that it failed to maintain the minimum $1 bid price required under Nasdaq Listing Rule 5550(a)(2) for at least 30 consecutive business days. The company is ineligible for a compliance period due to prior reverse stock splits exceeding the 250:1 cumulative threshold, and its securities will be suspended from trading on June 5, 2026 unless it successfully appeals to a Nasdaq Hearings Panel by June 3, 2026. This is a clear delisting risk disclosure under Item 3.01.
View raw filing on EDGAR →
8-K
Material Litigation
confidence 92%
filed 2026-05-29
Item 8.01
CEA Industries filed a complaint in U.S. District Court against 10X Capital LLC seeking to void an Asset Management Agreement as unconscionable and recover all fees paid since inception, or alternatively to invalidate a liquidated damages clause that would accelerate nearly 20 years of future fees. This is material litigation that directly affects the Company's financial obligations and contractual relationships, disclosed under Item 8.01 (Other Events).
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-29
Item 1.01
LyondellBasell entered into an Eighth Amendment to its structured accounts receivable facility, extending the term to June 2027 and reducing the maximum available amount from $900 million to $700 million. This amendment materially affects the Company's liquidity and financing structure.
View raw filing on EDGAR →
8-K
Auditor Change
confidence 98%
filed 2026-05-29
Item 4.01
The filing discloses a change in the Company's independent accountant, with Fruci & Associates II, PLLC resigning on May 5, 2026 at the Company's request, and KAN Accounting Solutions pllc engaged as the replacement on May 27, 2026. This is a classic auditor change under Item 4.01, and the disclosure confirms no prior consultations with the new auditor regarding accounting principles or reportable events, consistent with standard auditor-change disclosure requirements.
View raw filing on EDGAR →